Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCGEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBEEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.128EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.451EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.451EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.313EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.313EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ED.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.189EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used